A cancer stem cell origin for human endometrial carcinoma?

Reproduction

Volumn 140, Issue 1, 2010, Pages 23-32

  Hubbard, Sonya A ^a   Gargett, Caroline E ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD24 ANTIGEN; CD44V ANTIGEN; BIOLOGICAL MARKER; GLYCOPROTEIN; HERMES ANTIGEN; LEUKOCYTE ANTIGEN; PEPTIDE;

CANCER STEM CELL; CARCINOGENESIS; ENDOMETRIUM CARCINOMA; HISTOPATHOLOGY; HUMAN; INCIDENCE; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STEM CELL; CLASSIFICATION; CYTOLOGY; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; PATHOLOGY; PHYSIOLOGY;

ANTIGENS, CD; ANTIGENS, CD44; BIOLOGICAL MARKERS; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; GLYCOPROTEINS; HUMANS; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; PEPTIDES; PROGNOSIS;

EID: 77954186242     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-09-0411     Document Type: Review

References (74)

1. -/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clinical Cancer Research 11 1154-1159.
2. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ & Clarke MF 2003 Prospective identification of tumorigenic breast cancer cells. PNAS 100 3983-3988. (Pubitemid 36418143)
3. + ovarian cancer cells. Oncogene 28 209-218.
4. Bansal N, Yendluri V & Wenham RM 2009 The molecular biology of endometrial cancers and the implications for pathogenesis, classificiation, and targeted therapies. Cancer Control 16 8-13.
5. Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland AB, Shi Q, McLendon RE, Bigner DD & Rich JN 2006 Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Research 66 7843-7848.
6. Bapat SA, Mali AM, Koppikar CB & Kurrey NK 2005 Stem and progenitor-like cells contribute to the aggressive behaviour of human epithelial ovarian cancer. Cancer Research 65 3025-3029.
7. Becker L, Huang Q & Mashimo H 2008 Immunostaining of Lgr5, an intestinal stem cell marker, in normal and premalignant human gastrointestinal tissue. Scientific World Journal 8 1168-1176.
8. Bokhman JV 1983 Two pathogenetic types of endometrial carcinoma. Gynecologic Oncology 15 10-17.
9. Bonnet D & Dick JE 1997 Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine 3 730-737.
10. Chan RWS & Gargett CE 2006 Identification of label-retaining cells in mouse endometrium. Stem Cells 24 1529-1538.
11. Chan R, Schwab K & Gargett C 2004 Clonogenicity of human endometrial epithelial and stromal cells. Biology of Reproduction 70 1738-1750.
12. Choi D, Lee HW, Hur KY, Kim JJ, Park G-S, Jang S-H, Song YS, Jang K-S & Paik SS 2009 Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma. World Journal of Gastroenterology 15 2258-2264.
13. Chu P, Clanton DJ, Snipas TS, Lee J, Mitchell E, Nguyen M-L, Hare E & Peach RJ 2009 Characterization of a subpopulation of colon cancer cells with stem cell-like properties. International Journal of Cancer 124 1312-1321.
14. Clark EA, Golub TR, Lander ES & Hynes RO 2000 Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406 532-535.
15. Collins AT, Berry PA, Hyde C, Stower MJ & Maitland NJ 2005 Prospective identification of tumorigenic prostate cancer stem cells. Cancer Research 65 10946-10951.
16. Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL, Heintz APM, Ngan HYS & Pecorelli S 2006 Carcinoma of the corpus uteri. International Journal of Gynecology and Obstetrics 95 S105-S143.
17. Dalerba P, Dylla SJ, Park I-K, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM et al. 2007 Phenotypic characterization of human colorectal cancer stem cells. PNAS 104 10158-10163.
18. Di Cristofano A & Ellenson LH 2007 Endometrial carcinoma. Annual Review of Pathology. Mechanisms of Disease 2 57-85.
19. Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M et al. 2009 Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458 780-783.
20. Ferrandina G, Bonanno G, Pierelli L, Perillo A, Procoli A, Mariott A, Corallo M, Martinelli E, Rutella S, Paglia A et al. 2008 Expression of CD133-1 and CD133-2 in ovarian cancer. International Journal of Gynecological Cancer 18 506-514.
21. Ferrandina G, Martinelli E, Petrillo M, Prisco M, Zannoni G, Sioletic S & Scambia G 2009 CD133 antigen expression in ovarian cancer. BMC Cancer 9 221.
22. Fidler IJ & Kripke ML 1977 Metastasis results from preexisting variant cells within a malignant tumor. Science 197 893-895.
23. FIGO, The International Federation of Gynecology and Obstetrics 1989 Announcements. Gynecologic Oncology 35 125-127.
24. Fillmore C & Kuperwasser C 2007 Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties inmice or in man? Breast Cancer Research 9 303.
25. Friel AM, Sergent PA, Patnaude C, Szotek PP, Oliva E, Scadden DT, Seiden MV, Foster R & Rueda BR 2008 Functional analyses of the cancer stem cell-like properties of human endometrial tumor initiating cells. Cell Cycle 7 242-249.
26. Fuchs E, Tumbar T & Guasch G 2004 Socializing with the neighbours: stem cells and their niche. Cell 116 769-778.
27. Gargett CE 2007 Uterine stem cells: what is the evidence? Human Reproduction Update 13 87-101.
28. Gargett CE, Chan RWS & Schwab KE 2008 Hormone and growth factor signaling in endometrial renewal: role of stem/progenitor cells. Molecular and Cellular Endocrinology 288 22-29.
29. Gargett CE, Schwab KE, Zilwood RM, Nguyen HPT &Wu D 2009 Isolation and culture of epithelial progenitors and mesenchymal stem cells from human enodmetrium. Biology of Reproduction 80 1136-1145.
30. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S et al. 2007 ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1 555-567.
31. Gorai I, Yanagibashi T, Taki A, Udagawa K, Miyagi E, Nakazawa T, Hirahara F, Nagashima Y & Minaguchi H 1997 Uterine carcinosarcoma is derived from a single stem cell: an in vitro study. International Journal of Cancer 72 821-827.
32. Götte M, Wolf M, Staebler A, Buchweitz O, Kelsch R, Schüring AN & Kiesel L 2008 Increased expression of the adult stem cell marker Musashi-1 in endometriosis and endometrial carcinoma. Journal of Pathology 215 317-329.
33. Hamburger AW & Salmon SE 1977 Primary bioassay of human tumor stem cells. Science 197 461-463.
34. Heppner GH 1984 Tumor heterogeneity. Cancer Research 44 2259-2265.
35. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ & Heeschen C 2007 Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1 313-323. (Pubitemid 47355323)
36. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A et al. (Eds) 2009 SEER Cancer Statistics Review, 1975-2006. Bethesda, MD: National Cancer Institute. http://seer.cancer. gov/csr/1975-2006/
37. Horst D, Kriegl L, Engel J, Kirchner T & Jung A 2008 CD133 expression is an independent prognostic marker for low survival in colorectal cancer. British Journal of Cancer 99 1285-1289.
38. Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H, Fields JZ, Wicha MS & Boman BM 2009 Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Research 69 3382-3389.
39. Hubbard SA, Friel AM, Kumar B, Zhang L, Rueda BR & Gargett CE 2009 Evidence for cancer stem cells in human endometrial carcinoma. Cancer Research 69 8241-8248.
40. Jiang F, Qiu Q, Khanna A, Todd NW, Deepak J, Xing L, Wang H, Liu Z, Su Y, Stass SA et al. 2009 Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Molecular Cancer Research 7 330-338.
41. Kelly PN, Dakic A, Adams JM, Nutt SL & Strasser A 2007 Tumor growth need not be driven by rare cancer stem cells. Science 317 337.
42. Kern SE & Shibata D 2007 The fuzzy math of solid tumor stem cells: a perspective. Cancer Research 67 8985-8988.
43. Klonisch T, Wiechec E, Hombach-Klonisch S, Ande SR, Wesselborg S, Schulze-Osthoff K & Los M 2008 Cancer stem cell markers in common cancers - therapeutic implications. Trends in Molecular Medicine 14 450-460.
44. Kusumbe AP, Mali AM & Bapat SA 2009 CD133-expressing stem cells associated with ovarian metastases establish an endothelial hierarchy and contribute to tumor vasculature. Stem Cells 27 498-508.
45. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA & Dick JE 1994 A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367 645-648.
46. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF & Simeone DM 2007 Identification of pancreatic cancer stem cells. Cancer Research 67 1030-1037.
47. Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, Asselin-Labat M-L, Gyorki DE, Ward T, Partanen A et al. 2009 Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nature Medicine 15 907-913.
48. Mani SA, Guo W, Liao M-J, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M et al. 2008 The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133 704-715.
49. O'Brien CA, Pollett A, Gallinger S & Dick JE 2007 A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445 106-110.
50. + prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25 1696-1708.
51. +α2-β1+ cell population is enriched in tumor-initiating cells. Cancer Research 67 6796-6805.
52. Petrie K, Zelent A & Waxman S 2009 Differentiation therapy of acute myeloid leukemia: past, present and future. Current Opinion in Hematology 16 84-91.
53. Pilkington GJ 2005 Cancer stem cells in the mammalian central nervous system. Cell Proliferation 38 423-433.
54. Prat J, Gallardo A, Cuatrecasas M & Catasus L 2007 Endometrial carcinoma: pathology and genetics. Pathology 39 72-87.
55. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF & Ailles LE 2007 Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. PNAS 104 973-978.
56. Reya T, Morrison SJ, Clarke MF &Weissman IL 2001 Stem cells, cancer, and cancer stem cells. Nature 414 105-111.
57. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C & De Maria R 2007 Identification and expansion of human colon-cancer- initiating cells. Nature 445 111-115.
58. Rosen JM & Jordan CT 2009 The increasing complexity of the cancer stem cell paradigm. Science 324 1670-1673.
59. Rutella S, Bonanno G, Procoli A, Mariotti A, Corallo M, Prisco MG, Eramo A, Napoletano C, Gallo D, Perillo A et al. 2009 Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors. Clinical Cancer Research 15 4299-4311.
60. Ryan A, Susil B, Jobling T & Oehler M 2005 Endometrial cancer. Cell Tissue Research 322 53-61.
61. Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, Gasser M, Zhan Q, Jordan S, Duncan LM, Weishaupt C et al. 2008 Identification of cells initiating human melanomas. Nature 451 345-349.
62. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD & Dirks PB 2004 Identification of human brain tumour initiating cells. Nature 432 396-401.
63. Southam CM & Brunschwig A 1961 Quantitative studies of autotransplantation of human cancer. Preliminary report. Cancer 14 971-978.
64. Sureban SM, May R, George RJ, Dieckgraefe BK, McLeod HL, Ramalingam S, Bishnupuri KS, Natarajan G, Anant S & Houchen CW 2008 Knockdown of RNA binding protein Musashi-1 leads to tumor regression in vivo. Gastroenterology 134 1448-1458.
65. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, MacLaughlin DT & Donahoe PK 2006 Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. PNAS 103 11154-11159.
66. Tirino V, Camerlingo R, Franco R, Malanga D, La Rocca A, Viglietto G, Rocco G & Pirozzi G 2009 The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer. European Journal of Cardio-Thoracic Surgery 36 446-453.
67. Tokar EJ, Ancrile BB, Cunha GR & Webber MM 2005 Stem/progenitor and intermediate cell types and the origin of human prostate cancer. Differentiation 73 463-473.
68. Vermeulen L, Todaro M, de Sousa Mello F, Sprick MR, Kemper K, Alea MP, Richel DJ, Stassi G & Medema JP 2008 Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. PNAS 105 13427-13432.
69. Visvader JE & Lindeman GJ 2008 Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nature Reviews. Cancer 8 755-768.
70. Wu C, Wei Q, Utomo V, Nadesan P, Whetstone H, Kandel R, Wunder JS & Alman BA 2007 Side population cells isolated from mesenchymal neoplasms have tumor initiating potential. Cancer Research 67 8216-8222.
71. Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, Chu PWK, Lam CT, Poon RTP & Fan ST 2008 Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 13 153-166.
72. Zaino RJ 2009 FIGO staging of endometrial adenocarcinoma: a critical review and proposal. International Journal of Gynecological Pathology 28 1-9.
73. Zeppernick F, Ahmadi R, Campos B, Dictus C, Helmke BM, Becker N, Lichter P, Unterberg A, Radlwimmer B & Herold-Mende CC 2008 Stem cell marker CD133 affects clinical outcome in glioma patients. Clinical Cancer Research 14 123-129.
74. Zhang S, Balch C, Chan MW, Lai H-C, Matei D, Schilder JM, Yan PS, Huang THM & Nephew KP 2008 Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Research 68 4311-4320.